Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002897131 | SCV003649630 | uncertain significance | Inborn genetic diseases | 2022-09-27 | criteria provided, single submitter | clinical testing | The c.4867G>T (p.A1623S) alteration is located in exon 21 (coding exon 21) of the MED13L gene. This alteration results from a G to T substitution at nucleotide position 4867, causing the alanine (A) at amino acid position 1623 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |